Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
28.16
-0.32 (-1.12%)
Sep 29, 2026, 12:04 PM EDT - Market open
Neurogene Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Neurogene stock has a consensus rating of "Strong Buy" and an average price target of $80.43. The average 1-year stock price forecast is 185.62% higher than the current stock price, while the lowest is $46 (+63.35%) and the highest is $166 (+489.49%).
Price Target: $80.43 (+185.62%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 13, 2026.
Analyst Ratings
The average analyst rating for Neurogene stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 9 | 9 | 9 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $46 | Buy | Reiterates | $46 | +63.35% | Aug 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $180 → $166 | Buy | Maintains | $180 → $166 | +489.49% | Aug 12, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $69 → $81 | Buy | Maintains | $69 → $81 | +187.64% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 → $65 | Buy | Reiterates | $70 → $65 | +130.82% | Aug 12, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.66
from -4.24
EPS Next Year
-5.18
from -5.66
EPS and Forward PE are based on non-GAAP adjusted numbers.